Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion by Kanai, T et al.
Several investigators have demonstrated that human colon cancers
were extensively infiltrated by lymphocytes and that this infiltra-
tion is associated with improved survival (Murray et al, 1975;
Carlon et al, 1985; DiGiorgio et al, 1992). However, tumour infil-
trating lymphocytes (TILs) isolated from colon cancer tissues
were expanded after culture in the presence of interleukin (IL)-2,
but have failed to lyse autologous tumours in cytotoxicity assays
(Yoo et al, 1990; Home et al, 1993). Anti-tumour effects of colon
cancer-derived TILs may be mediated by cytokine secretion. Little
is known about cytokine production from colon cancer-derived
TILs and its functional role.
The human colon cancer cell line colo205 established from
ascitic fluid of patients with poorly differentiated colorectal carci-
noma has a unique morphological character that it grows non-
adherently like haematopoietic cell lines (Semple et al, 1978).
colo205 cells gradually show the cobblestone-like flat morphology
and adhere closely to plastic after confluent condition, indicating
that those cells differentiate into well-differentiated stage. We have
reported that interferon-g (IFN-g) induced cell–cell adhesion of
colo205 before the confluent stage (Kanai et al, 1993). This IFN-g-
induced aggregation was completely inhibited by anti-carcino-
embryonic antigen (CEA) monoclonal antibody (mAb). In
contrast to Th1 cytokine IFN-g, the effect of Th2 cytokines such as
IL-4 in the cell–cell adhesion of colo205 remains unclear. IL-13 is
a cytokine that shares structural characteristics with IL-4, and has
been found to mirror the effects of IL-4 in a wide variety of cells
(Zurawski and deVries, 1994). Obiri et al reported that IL-4
receptor (IL-4R) and IL-13 receptor (IL-13R) are expressed on
human colon cancer cells and these receptors may have a func-
tional role (Obiri et al, 1993, 1996).
To assess the role of IL-4 and IL-13 in colon cancer cell adhe-
sion, we investigated the effect of both cytokines in human colon
cancer cell line colo205 cell–cell adhesion. In the present study,
we demonstrated that IL-4 and IL-13 inhibited colon cancer
cell–cell adhesion by down-regulation of E-cadherin and CEA
molecules. Moreover, we demonstrated that TILs isolated from
patients with colon cancer expressed IL-4 and IL-13. These results
indicate that IL-4 and IL-13 may be involved in the regulation of
colon cancer cell adhesion. Therefore, our study raises the ques-
tion that cytokine secretion by colon cancer-derived TIL may lead
to tumour progression by lack of adhesiveness of tumour cells in
addition to its anti-tumour effect.
MATERIALS AND METHODS
Cell lines
The human poorly differentiated colorectal carcinoma cell line
(colo205) was obtained from ATCC (Rockville, MD, USA). The
cell culture and all assays in this study were performed in RPMI-
1640 supplemented with 10% fetal calf serum (FCS), 2 mM gluta-
mine, 1% penicillin–streptomycin and 5 ´ 10–5 M 2-ME.
Cytokines and reagents
Recombinant human IL-4 and IL-13 were purchased from
Pharmingen (San Diego, CA, USA). Recombinant human IFN-g
was kindly provided by the Shionogi Pharmaceutical Co. (Osaka,
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DOI: 10.1054/ bjoc.2000.1113, available online at http://www.idealibrary.com on Japan). Phytohaemagglutinin (PHA), phorbol 12-myristate 13-
acetate (PMA), Ca ionophore and brefeldin A were obtained from
Sigma (St Louis, MO, USA).
Monoclonal antibodies
The fluorescein isothiocyanate (FITC)-conjugated goat polyclonal
anti-mouse IgG was purchased from TAGO (Burlingame, CA,
USA). The mAb C3080 (anti-human CEA) was purchased from
Immunotech (Marseille, France). The mAb HECD-1 (anti-human
E-cadherin) was purchased from Takara Biomedicals (Tokyo,
Japan). The mAb 8D4-8 (anti-human IL-4) and the mAb B69-2
(anti-human IL-13) were purchased from Pharmingen (San Diego,
CA, USA). The mAb IT2.2 (anti-human B7-2) was kindly
provided from Dr Miyuki Azuma (National Children’s Medical
Research Center, Tokyo). Isomatched mouse IgG1 and strepta-
vidin–FITC were purchased from Sigma.
Cell–cell adhesion by phase-contrast microscopy
Cell–cell adhesion was assessed by the formation of cell aggre-
gates determined by at least two investigators using a phase-
contrast microscopy. Initial numbers of plated cells were 1 ´ 105.
Percentage of aggregated cells was calculated according to the
formula; (number of single cells)/(total number of cells) ´ 100.
To investigate the role of adhesion molecules during morpho-
logical changes of colo205 cells, we assessed the effect of anti-
CEA and anti-E-cadherin mAbs on the colo205 cell–cell adhesion.
Briefly, 3 ´ 103 colo205 cells per well (96-well flat bottom
microplates) were cultured with anti-CEA mAb mAb (2 mg ml–1)
or anti-E-cadherin (2 mg ml–1) alone, or in combination of both
mAbs for 24–48 h.
Effect of IL-4 on cell proliferation
Effect of IL-4 on cell growth was also determined by counting
viable cells on day 0 to day 6 after culturing in 24-well culture
plates. Initial cell numbers on day 0 were 1 ´ 105. Cultures in the
absence or presence of rhIL-4 were set up in triplicate in 2-ml
culture medium for each time point. At each point, cells from indi-
vidual wells were harvested and counted under a microscope with
a haemocytometry using a trypan blue viability assay.
IL-4 and IL-13 mRNA expression by reverse
transcriptase-polymerase chain reaction analysis
Total RNA was isolated from 1.0 ´ 106 colo205 cells, 1.2 ´ 106
TILs and 1.0 ´ 106 PHA (10 mg ml–1)-stimulated peripheral blood
mononuclear cells (PBMC) using RNAzol (Cinna/Biotech Lab,
Houston, TX, USA). RNA was also isolated from biopsied speci-
mens of normal colonic mucosa and colon cancer tissues. One
hundred nanograms each of total RNA was then reverse tran-
scribed in the presence of RAV 2 reverse transcriptase (BRL,
Bethesda, MD, USA). For cDNA synthesis, 4 ng ml–1 of total
cellular RNA solution was heated at 65°C for 5 min and cooled
rapidly. After adding 1 ml of 10 ´ polymerase chain reaction
(PCR) buffer (500 mM potassium chloride (KCl), 100 mM
Tris–HCl buffer, pH 8.4, 15 mM magnesium chloride (MgCl),
0.01% gelatin), 1 ml of 25 mM aNTP (Takara), 1 ml of 10 ´ hexa-
nucleotide mixture (Boehringer Mannheim, Mannheim, Germany),
1 ml of 100 mM dithiothreitol (Boehringer Mannheim), 20 U of
ribonuclease inhibitor (Takara), and 3 U of RNA-2 reverse tran-
scriptase, the mixture was incubated at 42°C for 60 min, heated at
94°C for 5 min, and quick-chilled on ice. PCR was performed to
amplify the cDNA of IL-4, IL-13, IL-4 receptor a (IL-4Ra),
common g chain (gc) and glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH). Equal amounts of cDNA were used in each PCR.
The PCR reaction mixture contained 10 ml of cDNA, 5 ml of 10 ´
PCR buffer, 8 ml of 1.25 mM a NTP, 207 ml of DEPC-water, 5 ml
each of 20 pM 5¢ and 3¢ primers and 1.5 U of Taq polymerase
(Perkin-Elmer Cetus, Norfork, CT, USA). To amplify the cDNA of
IL-4, IL-4Ra, gc, and GAPDH, the amplification was conducted at
94°C for 1 min, at 60°C for 2 min, at 72°C for 3 min for 40 cycles
for IL-4, IL-13, IL-4Ra, gc and GAPDH. The forward and reverse
human IL-4 primers were 5¢ primer, CGG CAA CTT TGA CCA
CGG ACA CAA GTG CGA TA and 3¢ primer, ACG TAC TCT
GGT TGG CTT CCT TCA CAG BGA CAG. The forward and
reverse human IL-13 primers were 5¢ primer, TGC CTC CCT CTA
CAG CCC TCA and 3¢ primer, CAG TTG AAC CGT CCC TCG
CG. The forward and reverse human IL-4Ra primers were 5¢
primer, TGA AGT CTG GGA TTT CCT ACA GGG CAC G and
3¢ primer, TCA AAC AAC TCC ACA CAT CGC ACC ACG C.
The forward and reverse human gc primers were 5¢ primer, GAA
GAC ACC ACA GCT GAT TTC and 3¢ primer, ACT CTC AGC
CAG TCC CTT AGA. The forward and reverse GAPDH primers
were 5¢ primer, TGA AGG TCG GTG TGA ACG GAT TTG GC
and 3¢ primer, CAT GTA GGC CAT GAG GTC CAC CAC
(Mapping Amplimers, Clonotech). All specific primers, synthesized
by the phosphoramine method using a DNA synthesizer (model 392
PCR-MATA; Applied Biosystems, Inc., Foster City, CA, USA)
were purchased from Sawady Technology (Tokyo, Japan).
Cell surface expression of adhesion molecules and
cytokine receptors by flow cytometry analysis
Examination of IL-4R, IL-13R, and IFN-g receptor (IFN-gR)
expression on cell surface by FACScan (Becton-Dickinson,
Mountain View, CA, USA) was carried out using biotin-labelled
IL-4, IL-13, and IFN-g as previously described (Fanslow et al,
1993). Briefly, biotin-N-hydroxysuccinimide (Calbiochem, La
Jolla, CA, USA) and purified human recombinant IL-4, IL-13,
and IFN-g were mixed at a molar ratio of 12:1. One hundred
microlitres each of IL-4 (1 mg ml–1), IL-13 (0.1 mg ml–1) and
IFN-g (0.1 mg ml–1) in 0.1 M NaHCO3, pH 8.5 were mixed with
10 ml biotin-N-hydroxysuccinimide (1 mg ml–1 in dimethyl
sulphoxide) for 30 min at room temperature, voltexing every 
10 min. At the end of the incubation period, the reaction mixture
was thoroughly dialysed in PBS and adjusted to 10 mg ml–1 in
PBS plus 0.01% NaN3. For IL-4R, IL-13R and IFN-gR determi-
nation, 5 ´ 105 colo205 cells were incubated with 50 ng biotiny-
lated IL-4, IL-13 or IFN-g in a volume of 100 ml PBS + 0.02%
NaN3, 2% heat-inactivated FCS for 30 min at 4°C. After washing
three times, cells were further incubated in 50 ml of diluted strep-
tavidin–FITC for 30 min at 4°C. Cells were washed three times
and analysed by the FACScan (Becton-Dickinson, Mountain
View, CA, USA).
To estimate the quantity the CEA and E-cadherin expression on
colo205 cells, flow cytometric analysis was done. The cells were
harvested using 0.25% trypsin, washed with PBS three times, and
then incubated with anti-E-cadherin mAb, anti-CEA mAb or
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FITC-conjugated goat anti-mouse IgG, the cells were suspended at
1 ´ 106 cells ml–1 and the fluorescence intensity on the surface of
the cells was analysed with a FACScan.
Isolation of TILs
Tissue samples were obtained with informed consent, from two
patients with colorectal cancer. Mucosal samples included macro-
scopically and microscopically cancerous areas and unaffected
normal areas of the colon. Tissues were minced with scissors, and
then digested with 0.4% collagenase (Sigma) solution in RPMI-
1640 supplemented with 50 mg ml–1 gentamicin (GIBCO). After
washing the tumour/lymphoid single cell suspension, tumour cells
were separated from TILs by discontinuous Ficool-Paque gradient
of 40% and 60% Percoll, and washed in RPMI-1640 medium.
Viability and purity was assessed by trypan blue dye exclusion.
Flow cytometry analysis of IL-4 and IL-13 expression in
colon cancer TILs
To investigate IL-4 and IL-13 at protein level, freshly isolated
TILs were cultured in 24-well plates (2 ´ 106 ml–1) for 24 h at 37°C
and 5% carbon dioxide in RPMI-1640 supplemented with 2 mM
glutamine, 100 IU ml–1 penicillin, 100 mg ml–1 streptomycin, and
10% FCS. Cells were stimulated with PMA (10 ng ml–1)+ Ca
ionophore (20 ng ml–1) in the presence of 10 mg ml–1 brefeldin A.
Brefeldin A was added at the beginning of the culture for a
maximum of 12 h to inhibit protein secretion.
RESULTS
IL-4 inhibits colo205 cell–cell adhesion
mRNA expression of IL-4R, that is comprised of two chains, IL-
4Ra chain and common g (gc) chain, in colo205 cells was analysed
by RT-PCR analysis. IL-4Ra chain mRNA was detected in
colo205 cells (Figure 1A). gc chain mRNA was also detected in
colo205 cells. To confirm the expression of IL-4R in colonic
epithelial cells, we analysed expression in colo205 cells by flow
cytometry. As shown in Figure 1B, colo205 cells clearly expressed
IL-4R on the cell surface. IFN-g receptor was also expressed on
colo205 cells as previously reported (Kanai et al, 1993).
colo205 cells changed their morphological shapes from floating
and round cells to adherent and cobblestone-like cells after
confluent stage (Figure 2A). Most cells in medium with IL-4 did
not change shape, and kept floating and were round in morphology
(Figure 2C, D). In contrast, IFN-g induced strong cell–cell aggre-
gation (Figure 2B). To assess the formation of cell adhesion,
percentage of single cells were then determined under phase-
contrast microscopy. As shown in Figure 3, IL-4 inhibited colo205
cell–cell adhesion in a dose-dependent fashion. Moreover, IFN-g
induced cell–cell adhesion was significantly (P < 0.05) decreased
by exogenous IL-4 (Figure 3).
To assess the effect of IL-4 in the proliferation of colo205 cells,
viable cells were counted at various time points. The cell counts in
colo205 cultures with various concentrations of IL-4 were almost
the same as that in the culture of untreated colo205 cells at given
point of time (Figure 4). We also examined the effect of IL-4 on
the incorporation of thymidine into the DNA of colo205 cells and
could not detect any significant difference between IL-4-treated
and untreated cells (data not shown).
IL-4 induced down-regulation of the expression of CEA
and E-cadherin molecules in colo205 cells
To elucidate the role of adhesion molecules during morphological
changes of colo205 cells, we assessed the effect of anti-CEA and
anti-E-cadherin mAbs on the colo205 cell–cell adhesion. As
shown in Figure 5, anti-CEA (2 mg ml–1) and anti-E-cadherin 
(2 mg ml–1) mAbs but not control anti-B7-2 (2 mg ml–1) mAb inhib-
ited colo205 cell–cell adhesion at 24 h (Figure 5A) and 48 h
(Figure 5B). As shown in Figure 5C, combination of anti-CEA and
Effect of IL-4 and IL-13 on colon cancer cell adhesion 1719
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Figure 1 (A) Common g (gc) chain and IL-4a receptor chain mRNA
expression in colo205 cells by RT-PCR. mRNA from PHA-stimulated PBMC
was served as positive control. (B) IL-4 receptor and IFN-g receptor
expression on the cell surface of colo205 cells. Flow cytometric histograms of
colo205 cells are shown. colo205 cells were incubated with biotinylated IL-4
or IFN-g followed by staining with FITC-conjugated streptavidin. Control cells
represent the background fluorescence of the cells stained with FITC-
conjugated streptavidinanti-E-cadherin mAbs significantly inhibited colo205 cell–cell
adhesion, as compared with anti-CEA mAb or anti-E-cadherin
mAb alone did. This result indicated that E-cadherin and CEA are
important molecules for colo205 cell–cell adhesion. We then
analysed the expression of E-cadherin and CEA in colo205 cells
by flow cytometry after cytokine treatment. As shown in Figure 6,
E-cadherin and CEA molecules were down-regulated by IL-4
treatment. In contrast, E-cadherin and CEA molecules were
constitutively expressed in untreated colo205 cells, and these
molecules were up-regulated by IFN-g treatment. Non-specific
cross-reacting antigen (NCA) that is a CEA family was also down-
regulated by IL-4 treatment (data not shown). These results
indicated that IL-4 inhibited colon cancer cell–cell adhesion by
down-regulation of E-cadherin and CEA molecules.
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Figure 2 Phase-contrast microscopic pictures of untreated (A), IFN-g
(100 U ml–1)-treated (B), IL-4 (1 U ml–1)-treated (C) and IL-4 (100 U ml–1)-
treated (D) colo205 cells at 96 h after treatment. Similar results were
obtained in each of five independent experiments
Figure 4 Effect of IL-4 on colo205 cell growth measured by trypan blue
viability cell counting. Cell counts of colo205 were assessed after treatment
with 1–100 U ml–1 IL-4. Initial cell counts on day 0 were 1 ´ 105
Figure 3 IL-4 inhibited cell–cell adhesion of colo205 cells. Subconfluent
cells were incubated with IL-4 (1–100 ng ml–1), IFN-g (1–100 U ml–1), or IFN-g
(10 U ml–1)+IL-4 (1–100 ng ml–1) for 24 h. After incubation, numbers of single
cells and total cells were measured by phase-contrast microscopy. The
percentage of single cells (number of single cells/number of total cells) is
represented
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Figure 5 Effect of various mAbs against adhesion molecules in colo205
cell–cell adhesion at 24 h (A) and 48 h (B) after treatment. Cell–cell adhesion
was assessed by the formation of cell aggregates determined by at least two
investigators using a phase-contrast microscopy. (C) Effect of combination of
anti-CEA and anti-E-cadherin mAbs on colo205 cell–cell adhesion at 24 h.
Percentage of aggregated cells was calculated according to Materials and
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Figure 6 Expression of E-cadherin and CEA molecules in colo205 cells. Cells were treated with IL-4 (100 U ml–1) or IFN-g (100 U ml–1) for 72 h. Single-cell
suspensions were stained with anti-E-cadherin or anti-CEA mAb followed by FITC-labelled goat anti-mouse IgG antibody. Dotted lines show the profiles of cells
stained with control mouse IgG antibody and second antibody. Representative of three experiments was shown. Data are presented as histograms of relative
number of cells (y-axis) versus fluorescence intensity (x-axis, log scale).
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Figure 7 (A) Phase-contrast microscopic pictures of untreated, IL-4-treated (100 U ml–1), IL-13 (10 ng ml–1)-treated, or IFN-g (100 U ml–1)-treated colo205 cells
at 2 and 6 days after treatment. Similar results were obtained in each of five independent experiments. (B) IL-13 inhibited cell–cell adhesion of colo205 cells.
Subconfluent cells were incubated with IL-13 (0.1–10 ng ml–1), or IFN-g (10 U ml–1)+IL-13 (0.1–10 ng ml–1) for 24 h. After incubation, numbers of single cells and
total cells were measured by phase-contrast microscopy. The percentage of single cells (number of single cells/number of total cells) is represented. The figure
shows the results of average range in triplicate. (C) IL-13 receptor expression on the cell surface of colo205 cells by flow cytometric analysis.
AIL-13 inhibits colo205 cell–cell adhesion
Most cells in the medium with IL-13 did not change the shapes
and kept floating and round (Figure 7A). As shown in Figure 7B,
IL-13 inhibited colo205 cell–cell adhesion in a dose-dependent
fashion and partially inhibited IFN-g-induced cell–cell adhesion.
We also analysed IL-13 receptor expression on colo205 cells by
flow cytometry. As shown in Figure 7C, colo205 cells expressed
IL-13 receptor on the cell surface. These results indicated that
IL-13 also inhibited colon cancer cell–cell adhesion in a similar
manner to IL-4.
IL-4 and IL-13 expression in freshly-isolated colon
cancer TILs
RT-PCR analysis demonstrated that IL-4 and IL-13 mRNA was
expressed in biopsied specimens of colon cancer tissues as well as
those of normal colonic tissues (Figure 8A). Expression of both
IL-4 and IL-13 mRNA in colon cancer tissues was not increased as
compared with that in normal colonic tissues. We then assessed
IL-4 and IL-13 mRNA expression in freshly-isolated TILs from
colon cancer. Both cytokine mRNAs were demonstrated by RT-
PCR analysis (Figure 8B). To confirm the expression of IL-4 and
IL-13 in colon TILs, we analysed intracellular expression of IL-4
and IL-13 in cells stimulated with PMA+Ca ionophore in the pres-
ence of 10 mg ml–1 brefeldin A by flow cytometry. As shown in
Figure 8C, colon TILs expressed both IL-4 and IL-13 protein in
the cytoplasm. Expression of both IL-4 and IL-13 protein on
isolated TILs from colon cancer tissues was not increased as
compared with that in lamina propria T-cells from normal tissues
(data not shown).
DISCUSSION
Disrupted cell–cell adhesion is thought to be responsible for the
invasiveness and metastasis potential of colon cancer cell. In
poorly differentiated tumours, there are numerous small groups of
non-adhesive cells as well as isolated cancer cells. Little is known
about the role of cytokines in cellular properties that confer disor-
dered cohesiveness. We demonstrated in a previous study that Th1
cytokine IFN-g induces cell–cell adhesion of colo205 with up-
regulation of CEA molecule (Kanai et al, 1993). In contrast to
IFN-g, the effect of Th2 cytokines such as IL-4 and IL-13 which
shares structural and functional characteristics with IL-4 in the
cell–cell adhesion of colon cancer cells remains unclear. Lahm et
al has reported a morphological change in WiDr cells after expo-
sure to IL-4 (Lahm et al, 1994). Cells after IL-4 treatment acquired
a round morphology, while control cells grown in culture medium
alone showed the epithelial-like flat morphology and closely
attached to plastic. But they did not demonstrate the mechanism
underlying the phenomena. It has been widely accepted that
effector CD4+ T-cells are subdivided into two subsets Th1 and
Th2 on the basis of their cytokine profiles. Th1 and Th2 subsets
interact and regulate each other in functional activity.
Disproportion between Th1 and Th2 subsets is thought to be asso-
ciated with susceptibility to various phenomena. Therefore, it is
possible that Th2 cytokines as well as Th1 cytokine IFN-g may
regulate colon cancer cell–cell adhesion.
In the present study, we found that Th2 cytokines IL-4 and IL-
13 inhibited colon cancer cell–cell adhesion. Several investigators
reported an inhibitory effect of IL-4 on in vitro proliferation of
human cancer cell (Hoon et al, 1991; Morisaki et al, 1992; Obiri et
al, 1993; Lahm et al, 1994), while colorectal carcinoma cell lines
Co-115 and SW1116 showed no significant alteration of the prolif-
eration in the presence of IL-4 (Jung et al, 1993). We also could
not show any significant difference in cell proliferation between
IL-4-treated and untreated colo205 cells. These results suggest
that inhibitory effect of IL-4 and IL-13 on colon cancer cell–cell
adhesion is not due to inhibiting cell growth, and that IL-4 and 
IL-13 may serve as negative regulators of colon cancer cell–cell
adhesion.
It is well known that E-cadherin mediates cell–cell adhesion, and
changes of E-cadherin expression have been reported in human
carcinomas (Boyer et al, 1992). Examination of cancer tissues
demonstrated a correlation in the expression of E-cadherin relative
to the state of differentiation and dedifferentiation (Tamm et al,
1722 T Kanai et al
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Figure 8 (A) IL-4 and IL-13 mRNA expression in biopsied specimens of
normal colonic mucosa and colon cancer tissues by RT-PCR analysis.
(B) IL-4 and IL-13 mRNA expression in freshly-isolated colon cancer TILs
from colon cancer tissues by RT-PCR analysis. mRNA from PHA-stimulated
PBMC and colo205 cells was served as positive and negative control
respectively. (C) IL-4 and IL-13 protein expression on isolated colon cancer
TILs using intracellular staining method by flow cytometric analysis1994a, 1994b). Moreover, cancer cells with disrupted E-cadherin-
mediated adherent junction leads rapidly to cell–cell separation and
increased invasiveness. IL-6 down-regulates E-cadherin at free cell
borders of ductal breast cancer cell line ZR-75-1-TX cells, and
those cells became round in morphology. In the present study, we
demonstrated that E-cadherin may be involved in colo205 cell–cell
adhesion, and Th2 type cytokines IL-4 and IL-13 might inhibit
colon cancer cell–cell adhesion by down-regulation of E-cadherin.
The cell adhesion activity of CEA molecule expressed on the cell
surface of human colon cancer cells has been reported (Benchimol
et al, 1989). We showed that CEA expression on the membrane 
of colo205 cells was decreased after IL-4 treatment. This result
further strengthened our thought that IL-4 regulates colon cancer
adhesion by regulation of adhesion molecules.
Human colon cancers are infiltrated by lymphocytes and this TIL
infiltration is associated with improved survival (Murray et al, 1975;
Carlon et al, 1985; DiGiorgio et al, 1992). DiGiorgio et al have
reported that a poor prognosis was detected in patients with minor or
no lymphocytic infiltration and TILs reactivity in tumour was signif-
icantly related to a less advanced stage of disease and better differ-
entiated tumour (DiGiorgio et al, 1992). Cultured colon TILs are
able to recognize human colon tumour antigens and secrete
cytokines in response to tumour stimulation. Anti-tumour effects of
colon TILs are thought to be mediated by cytokine secretion.
DiGiorgio et al did not assess the cytokine production profiles in
colonic TILs (DiGiorgio et al, 1992). Barth et al reported that Th2
cytokines IL-4 and IL-10 are the most common cytokines expressed
by human colon cancer cell TIL in situ (Barth et al, 1996). We also
showed IL-4 and IL-13 mRNA expression in isolated TILs from
colon cancer tissues. In the present study, we demonstrated that Th2
cytokine IL-4 inhibited colon cancer cell–cell adhesion by down-
regulation of E-cadherin and CEA. Therefore, this raises the
question that cytokine secretion by colon cancer TIL may lead to
anti-tumour effect alone or also to tumour progression by dyshesive-
ness of tumour cells. We showed IFN-g receptor as well as IL-4 and
IL-13 receptor expression in the cell surface of isolated colon cancer
cells from the patients. IFN-g augmented cell–cell adhesion of
colo205 with up-regulation of adhesion molecules. Although we
could not show any direct evidence that inhibition of cell–cell adhe-
sion of colon cancer cells are involved in the process of invasion or
metastasis of cancer cells, these findings indicated that imbalance of
Th1 and Th2 cytokine production by TILs may regulate the tumour
progression in colon cancer. We found that a few colon cancer
patients with dominant Th2-type cytokine production in TILs devel-
oped liver metastasis (T Kanai, unpublished observation). In concern
with this finding, Kobayashi et al (1998) demonstrated that IL-4
treatment increased the number of pulmonary melanoma metastasis
in the lungs and number of metastasis was decreased with anti-IL-4
mAb treatment in mice. Therefore, Th1 and Th2 balance in TILs
may be the important factor for tumour progression by dyshesive-
ness of tumour cells. With our findings, the knowledge of pattern of
cytokine secretion in human colon cancer TILs may help to judge
malignant potential including invasiveness and metastasis in clinical
investigation.
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